| Trial ID: | L0709 |
| Source ID: | CTRI/2019/12/022578
|
| Associated Drug: |
Muliv Strong Syrup
|
| Title: |
An open label Clinical trial to evaluate the efficacy of Muliv Strong Syrup in the management of Non- Alcoholic Fatty Liver disease (NAFLD).
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Health Condition 1: K758- Other specified inflammatory liverdiseases
|
| Interventions: |
Intervention1: Muliv Strong Syrup: Muliv Strong Syrup orally 10 ml TDS before meal for 45 days<br>Control Intervention1: NIL: NIL<br>
|
| Outcome Measures: |
Changes in NAFLD ScoreTimepoint: 60 daysChanges in Subjective parameters, LFT, USGTimepoint: 60days
|
| Sponsor/Collaborators: |
Multani Pharmaceuticals Ltd
|
| Gender: |
--
|
| Age: |
nannan
|
| Phases: |
Phase 2
|
| Enrollment: |
50
|
| Study Type: |
Interventional
|
| Study Designs: |
Single Arm Trial<br> Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
|
| Start Date: |
31/12/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
24 November 2021
|
| Locations: |
India
|
| URL: |
http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=39432
|
